Search clinical trials for: 225Ac-PSMA-R2

Total 868 results

Novartis Pharmaceuticals

Active, not recruiting

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT (SatisfACtion)

Prostate Cancer

United States, France, Australia, Canada
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer
Xiaorong Sun

Recruiting

A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer Patients

China
Novartis Pharmaceuticals

Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy (PSMAcTION)

Prostate Cancer

United States, China, Australia, Singapore, Japan, Switzerland, Taiwan, Israel, Hong Kong, Malaysia, South Korea, Brazil
Andrei Iagaru

Completed

Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | PSA Progression

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe